Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,439 | 8,525 | 11,777 | 9,414 | 201 |
| Receivables | 6,558 | 5,087 | 3,554 | 1,557 | N/A |
| Inventories | 3,077 | 4,048 | 2,545 | 1,471 | N/A |
| TOTAL | $32,244 | $20,669 | $20,862 | $17,214 | $526 |
| Non-Current Assets | |||||
| PPE Net | 1,808 | 1,669 | 2,091 | 2,231 | N/A |
| Investments And Advances | 0 | 0 | 0 | 0 | 250,007 |
| Intangibles | 0 | 0 | 0 | 802 | 0 |
| Other Non-Current Assets | 1,279 | 1,633 | 1,645 | 1,748 | 0 |
| TOTAL | $3,087 | $3,302 | $3,736 | $4,781 | $250,007 |
| Total Assets | $35,331 | $23,971 | $24,598 | $21,995 | $250,533 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,002 | 2,274 | 3,391 | 4,947 | 1,058 |
| Accrued Expenses | 8,096 | 7,355 | 10,556 | 6,377 | N/A |
| Other current liabilities | 234 | 383 | 389 | 20,663 | N/A |
| TOTAL | $11,499 | $10,228 | $14,687 | $32,357 | $1,602 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,046 | 22,084 | 0 | N/A | N/A |
| Other Non-Current Liabilities | 24,647 | 17,553 | 36,976 | 165,968 | 256,899 |
| TOTAL | $57,693 | $39,637 | $36,976 | $165,968 | $265,649 |
| Total Liabilities | $69,192 | $49,865 | $51,663 | $198,325 | $267,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,306 | 32,272 | 26,758 | 8,203 | 31,250 |
| Common Shares | 4 | 3 | 2 | 0 | 1 |
| Retained earnings | -330,583 | -279,549 | -249,504 | -186,358 | -16,718 |
| TOTAL | $-33,861 | $-25,894 | $-27,065 | $-176,330 | $-16,717 |
| Total Liabilities And Equity | $35,331 | $23,971 | $24,598 | $21,995 | $250,533 |